{
"id":"mk19_b_hm_q033",
"number":33,
"bookId":"hm",
"correctAnswer":"A",
"title":"Question 33",
"stimulus":[
{
"type":"p",
"hlId":"4eb561",
"children":[
"A 30-year-old man is evaluated for progressive fatigue of several months' duration. Medical history is otherwise unremarkable. He indicates having a sibling. He takes no medications."
]
},
{
"type":"p",
"hlId":"19ca47",
"children":[
"On physical examination, pulse rate is 114/min; other vital signs are normal. ",
{
"type":"reference-range-link",
"referenceRange":"Blood gases, Oxygen saturation, arterial (ambient air)",
"children":[
"Oxygen saturation"
]
},
" is 98% breathing ambient air. Conjunctival rim pallor and scattered petechiae are noted."
]
},
{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"lab-values table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"a462a3",
"children":[
"Laboratory studies:"
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"f9867c",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Hemoglobin, blood",
"children":[
"Hemoglobin"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"708833",
"class":"cell text l",
"children":[
"7.1 g/dL (71 g/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"2989c0",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Leukocyte count",
"children":[
"Leukocyte count"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"7c23c4",
"class":"cell text l",
"children":[
"1200/μL (1.2 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L) (65% neutrophils, 35% lymphocytes)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"42dff3",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Mean corpuscular volume",
"children":[
"Mean corpuscular volume"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"66b39a",
"class":"cell text l",
"children":[
"90 fL"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"fcac73",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Platelet count",
"children":[
"Platelet count"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"72b682",
"class":"cell text l",
"children":[
"22,000/μL (22 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"7d8e6e",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Reticulocyte count",
"children":[
"Reticulocyte count"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"78dc6e",
"class":"cell text l",
"children":[
"1% of erythrocytes"
]
}
]
}
]
}
]
}
]
},
{
"type":"p",
"hlId":"949b6a",
"children":[
"Peripheral blood smear shows erythrocytes with normal morphology and decreased platelets. A bone marrow biopsy shows marked hypocellularity and increased fat content without dysplastic cells. Testing for viral hepatitis is negative."
]
},
{
"type":"p",
"hlId":"0346e0",
"children":[
"The sibling's test results show an HLA match."
]
}
],
"prompt":[
" ",
{
"type":"p",
"hlId":"0ded5d",
"children":[
"Which of the following is the most effective therapy?"
]
},
" "
],
"options":[
{
"letter":"A",
"text":{
"__html":"Allogeneic hematopoietic stem cell transplantation"
}
},
{
"letter":"B",
"text":{
"__html":"Antithymocyte globulin"
}
},
{
"letter":"C",
"text":{
"__html":"Azacytidine"
}
},
{
"letter":"D",
"text":{
"__html":"Intravenous immune globulin"
}
}
],
"keypoints":[
{
"type":"keypoint",
"hlId":"e03781",
"children":[
"Allogeneic hematopoietic stem cell transplantation is the preferred treatment for aplastic anemia in younger patients who have an HLA-matched stem cell donor."
]
},
{
"type":"keypoint",
"hlId":"125ebe",
"children":[
"In patients older than 50 years and in younger patients without a suitable stem cell donor, aplastic anemia is treated by immunosuppression with antithymocyte globulin, cyclosporine, and prednisone."
]
}
],
"exposition":[
{
"type":"p",
"hlId":"42f653",
"children":[
"The most effective treatment is allogeneic hematopoietic stem cell transplantation (HSCT) with an HLA-matched sibling (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option A"
]
},
"). The blood and bone marrow findings are consistent with aplastic anemia, an acquired hematopoietic stem cell disorder characterized by severely decreased bone marrow cellularity and pancytopenia. Although it is classified as an anemia, patients usually have a combination of anemia, neutropenia, and thrombocytopenia. The bone marrow typically shows marked hypocellularity with a commensurate increase in fat tissue. Typically, no dysplastic features of cell maturation are seen, as would be seen in the hypocellular variant of myelodysplastic syndrome, or an increase in cellularity and immature leukocytes, as would be seen in “aleukemic” acute leukemia. Younger patients with a suitable HLA-matched donor are usually treated with allogeneic HSCT. With advances in immunosuppression and supportive care, the overall survival of young patients following HSCT with a good risk profile is greater than 80%."
]
},
{
"type":"p",
"hlId":"347983",
"children":[
"Most aplastic anemia is felt to be related to stem cell autoimmunity. In patients older than 50 years and in younger patients without a suitable stem cell donor, autoimmune aplastic anemia is treated by immunosuppression with antithymocyte globulin, cyclosporine, and prednisone (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option B"
]
},
"). Allogenic HSCT is preferred in this younger patient."
]
},
{
"type":"p",
"hlId":"8ae92b",
"children":[
"Azacytidine or other hypomethylating agents may be useful in managing symptomatic patients with myelodysplastic syndrome, decreasing transfusion requirements and delaying conversion to acute leukemia. Azacytidine is not used in managing aplastic anemia (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option C"
]
},
")."
]
},
{
"type":"p",
"hlId":"65c548",
"children":[
"Intravenous immune globulin (IVIG) is useful in treating pure red cell aplasia, which is characterized by normocytic or macrocytic anemia with decreased reticulocytes and absent or decreased erythrocyte precursors in the bone marrow. Parvovirus B19 is cytotoxic to the erythrocyte precursors in the bone marrow. Immunocompromised patients can have sustained viremia leading to prolonged anemia requiring IVIG treatment to hasten viral clearance and recover erythrocyte production. IVIG has no role in managing aplastic anemia (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option D"
]
},
")."
]
}
],
"relatedSection":"mk19_b_hm_s2_2_1",
"objective":{
"__html":"Treat aplastic anemia."
},
"references":[
[
"Young NS. Aplastic anemia. N Engl J Med. 2018;379:1643-1656. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30354958",
"target":"_blank"
},
"children":[
"PMID: 30354958"
]
},
" doi:10.1056/NEJMra1413485"
]
],
"hospitalist":false,
"hvc":false,
"peerComparison":{
"A":80,
"B":17,
"C":1,
"D":2,
"E":0
},
"hlIds":[
"4eb561",
"19ca47",
"a462a3",
"f9867c",
"708833",
"2989c0",
"7c23c4",
"42dff3",
"66b39a",
"fcac73",
"72b682",
"7d8e6e",
"78dc6e",
"949b6a",
"0346e0",
"0ded5d",
"e03781",
"125ebe",
"42f653",
"347983",
"8ae92b",
"65c548"
]
}